What Next for Amedisys, Inc. (AMED) Stock After Touching 52-Week High?

May 18, 2018 - By Michael Collier

Amedisys, Inc. (NASDAQ:AMED) Logo

Investors sentiment increased to 1.77 in Q4 2017. Its up 0.06, from 1.71 in 2017Q3. It improved, as 12 investors sold Amedisys, Inc. shares while 44 reduced holdings. 39 funds opened positions while 60 raised stakes. 31.82 million shares or 0.22% more from 31.75 million shares in 2017Q3 were reported.
Boston Ltd Liability Corporation stated it has 0.06% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). Principal Grp Inc has invested 0.01% in Amedisys, Inc. (NASDAQ:AMED). Century Inc invested in 1.79 million shares or 0.09% of the stock. Kbc Grp Inc Nv reported 43,424 shares. Alliancebernstein Limited Partnership reported 87,473 shares or 0% of all its holdings. Quantitative Systematic Strategies Ltd Liability invested in 4,384 shares or 0.06% of the stock. Zebra Capital Management Lc invested in 19,931 shares or 0.36% of the stock. Aperio Group Incorporated Ltd Liability Com stated it has 16,952 shares or 0% of all its holdings. Barclays Public Limited reported 10,769 shares. State Board Of Administration Of Florida Retirement Systems holds 0% of its portfolio in Amedisys, Inc. (NASDAQ:AMED) for 19,658 shares. 12,361 are held by Koch Incorporated. California-based Parallax Volatility Advisers L P has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Hancock holds 123,910 shares. Assetmark Inc stated it has 0% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). Great West Life Assurance Can has invested 0% in Amedisys, Inc. (NASDAQ:AMED).

Since May 11, 2018, it had 0 insider buys, and 2 sales for $1.12 million activity. On Friday, May 11 the insider North Michael Paul sold $786,708.

The stock of Amedisys, Inc. (NASDAQ:AMED) hit a new 52-week high and has $76.74 target or 3.00 % above today’s $74.51 share price. The 5 months bullish chart indicates low risk for the $2.54 billion company. The 1-year high was reported on May, 18 by Barchart.com. If the $76.74 price target is reached, the company will be worth $76.14 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.11% or $0.085 during the last trading session, reaching $74.505. About 45,588 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 18.43% since May 18, 2017 and is uptrending. It has outperformed by 6.88% the S&P500.

Analysts await Amedisys, Inc. (NASDAQ:AMED) to report earnings on July, 25. They expect $0.78 EPS, up 25.81 % or $0.16 from last year’s $0.62 per share. AMED’s profit will be $26.57 million for 23.88 P/E if the $0.78 EPS becomes a reality. After $0.79 actual EPS reported by Amedisys, Inc. for the previous quarter, Wall Street now forecasts -1.27 % negative EPS growth.

Amedisys, Inc. (NASDAQ:AMED) Ratings Coverage

Among 6 analysts covering Amedisys (NASDAQ:AMED), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Amedisys has $8000 highest and $66.0 lowest target. $71.25’s average target is -4.37% below currents $74.505 stock price. Amedisys had 7 analyst reports since January 23, 2018 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, March 19 by RBC Capital Markets. The firm has “Buy” rating by Jefferies given on Wednesday, February 28. The company was maintained on Tuesday, January 23 by William Blair. As per Tuesday, May 8, the company rating was maintained by Robert W. Baird. The firm has “Hold” rating given on Thursday, March 1 by Robert W. Baird. On Tuesday, April 17 the stock rating was maintained by SunTrust with “Buy”. As per Thursday, March 29, the company rating was maintained by Oppenheimer.

More notable recent Amedisys, Inc. (NASDAQ:AMED) news were published by: Globenewswire.com which released: “Amedisys Welcomes Sharon Brunecz as Chief Human Resources Officer” on April 24, 2018, also Seekingalpha.com with their article: “Amedisys’ (AMED) CEO Paul Kusserow on Q1 2018 Results – Earnings Call Transcript” published on May 13, 2018, Globenewswire.com published: “Amedisys Celebrates More Than 5700 Nurses During National Nurses Week” on May 07, 2018. More interesting news about Amedisys, Inc. (NASDAQ:AMED) were released by: Nasdaq.com and their article: “Amedisys to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference” published on May 14, 2018 as well as Globenewswire.com‘s news article titled: “Amedisys Reports First Quarter 2018 Financial Results and Reaffirms 2018 Guidance” with publication date: May 07, 2018.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $2.54 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 84.66 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

Amedisys, Inc. (NASDAQ:AMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.